IMMURON (IMRN) vs Lunai Bioworks Inc. (LNAI)

IMMURON and Lunai Bioworks Inc. are both Biotechnology companies. IMMURON and Lunai Bioworks Inc. are of similar size ($9.6M and $8.8M). Lunai Bioworks Inc. has the higher net margin (0.00% vs −262.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, IMMURON leads on 7 and Lunai Bioworks Inc. on 2.

Valuation

Metric IMRN LNAI Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.93 n/m 0.74
EV/Sales (3.50) n/m 10.73
Earnings yield (1.75%) (3,132.07%) (28.84%)
Free cash flow yield 0.00% (86.80%) (23.03%)

Profitability

Metric IMRN LNAI Biotechnology median
Gross margin 71.28% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (262.71%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (325.46%) (57.72%)
Return on assets 0.00% (201.09%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMRN LNAI Biotechnology median
Revenue growth (TTM) (6.62%) — 5.64%
EPS growth (last fiscal year) 37.29% (28.38%) —
Revenue growth, 5-year CAGR 116.96% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMRN LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.17 0.19 4.73
Net debt to EBITDA 2.25 0.03 0.96

Dividend

Metric IMRN LNAI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IMRN LNAI Biotechnology median
Market cap 9.60m 8.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack